Niklas Dyrby Johansen

380 posts

Niklas Dyrby Johansen

Niklas Dyrby Johansen

@niklasdj1

MD, PhD. Postdoctoral researcher @CTCPR_. Cardiology fellow @Amager-Hvidovre Hospital.

København, Danmark Katılım Şubat 2013
226 Takip Edilen236 Takipçiler
Niklas Dyrby Johansen retweetledi
CTCPR Trials & CIRL
CTCPR Trials & CIRL@CTCPR_·
📩 Can digital nudges boost vaccination—year after year? In a nationwide RCT (n=308,978), @niklasdj1 & colleagues from @CTCPR_ (@NEJMEvidence) show: - Vaccination rates increased from 24.1% (usual care) → 36.5% (any letter) - All e-letters were effective - Best: repeated CV-focused message → 39.1% (+15.0 pp) 💡Scalable, low-cost nudges works—and persist across seasons. 📄 Study link: evidence.nejm.org/doi/10.1056/EV… @TorBiering @CopCard @RigsHeart @HGHHjerte @Stenodiabetes @KiraJanstrup
CTCPR Trials & CIRL tweet media
English
0
2
4
107
Niklas Dyrby Johansen retweetledi
CTCPR Trials & CIRL
CTCPR Trials & CIRL@CTCPR_·
New in @TheLancet @niklasdj1 & colleagues from @CTCPR_ report pooled data (FLUNITY-HD) from 466,320 older adults in Denmark & Spain. High-dose vs standard-dose influenza vaccine: ✅ 8.8% ↓ influenza/pneumonia hospitalization ✅ ↓ cardiorespiratory & all-cause hospitalization = Similar safety Large pragmatic RCT evidence with public health impact. 📄Study link: #preview-section-abstract" target="_blank" rel="nofollow noopener">sciencedirect.com/science/articl… @TorBiering @CopCard @RigsHeart @HGHHjerte @Stenodiabetes @RebeccaCHarris @matslassen @kristofferskaarup @AM_reimer @dons_maria @KBernholm @fdavidovski_MD @LisaSteenDuus @camillaiottosen @AnneBjergn @drJBorchsenius @Espersen_C @LiseWittenDavodian @AdamLanghoff @MortenSengelov @katjabartholdy
CTCPR Trials & CIRL tweet media
English
0
3
4
178
Niklas Dyrby Johansen retweetledi
CTCPR Trials & CIRL
CTCPR Trials & CIRL@CTCPR_·
🔎 New in @JAMANetwork @niklasdj1 and colleagues from @CTCPR_ tested whether digital invitation design affects trial enrollment within DANFLU-2 (n=934,049). 1-page letters outperformed 2-page versions 📄 Color made no difference 🎨 ~1% absolute difference = ~9,800 extra participants per 1M invites. In large pragmatic trials, simplicity matters. 📄 Study link: jamanetwork.com/journals/jama/… @TorBiering @CopCard @RigsHeart @HGHHjerte @Stenodiabetes @RebeccaCHarris
CTCPR Trials & CIRL tweet media
English
0
2
3
132
Niklas Dyrby Johansen retweetledi
CTCPR Trials & CIRL
CTCPR Trials & CIRL@CTCPR_·
🫀 KP-VACCINATE Megatrial in @AmHeartJ! @CTCPR_ collaborated on the KP-VACCINATE trial led by @ankeetbhatt and colleagues from Kaiser Permanente. 3.6M+ adults randomized to test whether cardiovascular (CV) focused messaging boosts influenza vaccination vs usual care. Key points: • Individually randomized, care-embedded design across two integrated health systems • Messaging emphasizes potential CV benefits of vaccination • Evaluates both effectiveness + optimal timing • Diverse US population across age, race/ethnicity & cardiometabolic risk KP-VACCINATE is the largest and most diverse individually randomized implementation trial conducted globally to date, offering scalable, low-cost strategies to improve vaccination coverage and support CV risk reduction. Full article: doi.org/10.1016/j.ahj.… @TorBiering @niklasdj1 @kpnorcal @KPMidAtlantic @CopCard @RigsHeart @HGHHjerte @Stenodiabetes
CTCPR Trials & CIRL tweet media
English
0
4
10
1.3K
Niklas Dyrby Johansen retweetledi
Ahmed Bennis MD 🫀
Ahmed Bennis MD 🫀@drbennisahmed·
High-Dose vs Standard-Dose Influenza Vaccine and Cardiovascular Outcomes in Older Adults A Prespecified Secondary Analysis of the DANFLU-2 Randomized Clinical Trial The results suggest additional effectiveness with HD-IIV compared with SD-IIV against cardiovascular outcomes but should be interpreted as exploratory findings in the setting of a large randomized clinical trial with a neutral primary outcome #Cardiology #MedTwitter #CardioTwitter #HeartHealth #Healthcare @DrMarthaGulati @hvanspall @AnastasiaSMihai @biljana_parapid @Hragy @JAMA_current @AndrewJSauer @ankeetbhatt @almucastro01 jamanetwork.com/journals/jamac…
Ahmed Bennis MD 🫀 tweet media
English
0
4
11
787
Niklas Dyrby Johansen retweetledi
Katja
Katja@katjabartholdy·
Happy to share results from the Danish NUDGE-FLU CHRONIC 1 trial at #AHA25 Nudges improved vaccination in all groups - but ethnic disparities persist. Even in the setting of universal access to healthcare, equity in prevention still needs attention. @CTCPR_
Katja tweet media
English
0
3
6
227
Niklas Dyrby Johansen retweetledi
NEJM Evidence
NEJM Evidence@NEJMEvidence·
Flu causes major illness and death yearly, but vaccination rates are falling. In a Danish RCT, electronic nudges significantly increased vaccination rates, with the largest effect size using repeated cardiovascular-focused nudges. eviden.cc/3JpZlI0 @AHAScience | #AHA25
NEJM Evidence tweet media
English
0
2
8
1.1K
Niklas Dyrby Johansen retweetledi
NEJM Evidence
NEJM Evidence@NEJMEvidence·
Volume 4 Issue 11 of 𝘕𝘌𝘑𝘔 𝘌𝘷𝘪𝘥𝘦𝘯𝘤𝘦 is now available! Here is a preview of the latest content: 𝗢𝗿𝗶𝗴𝗶𝗻𝗮𝗹 𝗔𝗿𝘁𝗶𝗰𝗹𝗲𝘀 Cardiac Effects of Dapagliflozin in People with Chronic Kidney Disease eviden.cc/46Wo93g
NEJM Evidence tweet media
English
1
9
21
10.6K
Niklas Dyrby Johansen retweetledi
CTCPR Trials & CIRL
CTCPR Trials & CIRL@CTCPR_·
NUDGE-FLU trial: Promoting one vaccine can influence uptake of another 🦠💉 A prespecified secondary analysis of the nationwide NUDGE-FLU trial by @niklasdj1,  and colleagues @CTCPR_ found that electronic letters promoting influenza vaccination slightly reduced COVID-19 vaccination uptake (−0.36 percentage points) in Danish adults ≥65 — but had no effect on COVID-19 infection or hospitalization. 💡 Highlights that interventions targeting a single vaccine may have unintended consequences on other preventive measures, emphasizing the importance of coordinated public health messaging. Published in @JAMANetworkOpen 📄 “COVID-19 Outcomes Among Adults Receiving Electronic Nudges to Increase Influenza Vaccination”  doi.org/10.1001/jamane… @TorBiering @ankeetbhatt @CopCard @RigsHeart @HGHHjerte @Stenodiabetes
CTCPR Trials & CIRL tweet media
English
0
2
4
226
Niklas Dyrby Johansen retweetledi
Niklas Dyrby Johansen retweetledi
Ankeet S. Bhatt, MD, MBA, ScM
Ankeet S. Bhatt, MD, MBA, ScM@ankeetbhatt·
At @escardio, we presented #KPVaccinate-to our knowledge the largest indiv. randomized trial ever. ⭕️>3.6 million pts randomized in 1 mo ⭕️Care embedded AB tests applicable to other #CKMHealth gaps ⭕️While no vaccine⏫, demonstrates feasibility of rapid trials at scale in a LHS
Ankeet S. Bhatt, MD, MBA, ScM tweet mediaAnkeet S. Bhatt, MD, MBA, ScM tweet mediaAnkeet S. Bhatt, MD, MBA, ScM tweet mediaAnkeet S. Bhatt, MD, MBA, ScM tweet media
English
4
13
32
3.9K
Niklas Dyrby Johansen retweetledi
Tor Biering-Sørensen, MD, MSc, MPH, PhD
I’m more than proud to lead a team of the most talented researchers I have ever met 👩‍🎓🧑🏽‍🎓Congratulations to the whole team with this accomplishment 👏 It’s an honor to work with and learn from you all 🙏 @CTCPR_ for the win 🌟
CTCPR Trials & CIRL@CTCPR_

🚨 An extraordinary achievement from all the @CTCPR_ researchers at ESC! Our researchers simultaneously published 13 papers across leading journals, showcasing some of the latest breakthroughs in cardiology. These publications include: · 3 in The New England Journal of Medicine · 1 in The Lancet · 1 in JAMA · 2 in European Heart Journal · 3 in Journal of the American College of Cardiology · 1 in JAMA Cardiology · 1 in JAMA Open · 1 in Circulation: Heart Failure This remarkable achievement reflects the dedication and collaboration of the @CTCPR_ team. Each study contributes valuable insights that hopefully will help improve patient care and inform clinical practice worldwide. 👏 Huge congratulations to all @CTCPR_ researchers and collaborators for their hard work, perseverance, and commitment to advancing science. @NEJM @thelancet @JAMANetwork @ESC_Journals @JACCJournals @JAMACardio @JAMANetworkOpen @CircHF

English
2
9
37
2.7K